David Wattel

David Wattel, MBA has a diverse work experience in the pharmaceutical and biotech industry, holding finance and accounting roles at companies such as Ambrx, Turning Point Therapeutics, Arena Pharmaceuticals, and Ultragenyx Pharmaceutical Inc. Their experience includes financial analysis, clinical trial accounting, and corporate finance. David has a strong background in FP&A, business operations, and investment analysis.

David Wattel, MBA obtained a Bachelor's Degree in Finance and Spanish from Santa Clara University Leavey School of Business. David then pursued their MBA in Finance at the University of Notre Dame - Mendoza College of Business. David also completed their high school education with an Academic Diploma with Honors from St. Vincent's De Paul High in Petaluma. In addition, they have obtained certifications in cybersecurity awareness and teamwork foundations from LinkedIn in 2023.